TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
TRIV was delisted on the 3rd of February, 2016.
35 hedge funds and large institutions have $184M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$59.9M |
| 2 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$27M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$23.4M |
| 4 |
DM
Deerfield Management
New York
|
+$22.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.2M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $87K | +$84.1K | +5,543 | New |
|
|
AIG
27
American International Group
New York
| $75.7K | +$73.8K | +4,860 | New |
|
28
Bank of America
Charlotte,
North Carolina
| $50K | +$48.5K | +3,196 | New |
|
|
GSC
29
Ground Swell Capital
Folly Beach,
South Carolina
| $41K | +$40.2K | +2,649 | New |
|
30
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $23K | +$22.7K | +1,497 | New |
|
31
AllianceBernstein
Nashville,
Tennessee
| $16K | +$15.2K | +1,000 | New |
|
|
VFA
32
Virtus Fund Advisers
Hartford,
Connecticut
| $10K | +$9.61K | +633 | New |
|
33
Wells Fargo
San Francisco,
California
| $8K | +$8.03K | +529 | New |
|
34
Barclays
London,
United Kingdom
| $2K | +$2.47K | +163 | New |
|
35
Citigroup
New York
| $1K | +$956 | +63 | New |
|
TRIV Hedge Fund Activity: Q2 2014 in Review
35 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q2 2014, worth a combined $184M.
Buyers outnumbered sellers: 35 funds opened new TRIV positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $59.9M.
- 35 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $184M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q2 2014.
- 35 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q2 2014 and 0 closed out, a net change of +35 holders.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q2 2014 was NEA Management Company, an estimated $59.9M added.
Based on aggregated 13F filings for Q2 2014.